2021
DOI: 10.1016/j.ejpb.2020.12.001
|View full text |Cite
|
Sign up to set email alerts
|

An integrated computational methodology with data-driven machine learning, molecular modeling and PBPK modeling to accelerate solid dispersion formulation design

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
28
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
2
1

Relationship

2
7

Authors

Journals

citations
Cited by 47 publications
(28 citation statements)
references
References 66 publications
0
28
0
Order By: Relevance
“…This study substantially advances the field of cancer nanomedicine by integrating ML and AI technologies with PBPK modeling to study cancer nanomedicine. ML and AI models are useful to predict PBPK-related parameters, such as in vitro dissolution rate, hepatic clearance, and membrane permeability of small molecular drugs; 54 , 55 and these parameters are in turn helpful to support PBPK model development. While ML and AI methods have been applied to support PBPK model development of small molecular drugs, 54 , 55 they have not been applied to develop PBPK models of nanomedicines.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…This study substantially advances the field of cancer nanomedicine by integrating ML and AI technologies with PBPK modeling to study cancer nanomedicine. ML and AI models are useful to predict PBPK-related parameters, such as in vitro dissolution rate, hepatic clearance, and membrane permeability of small molecular drugs; 54 , 55 and these parameters are in turn helpful to support PBPK model development. While ML and AI methods have been applied to support PBPK model development of small molecular drugs, 54 , 55 they have not been applied to develop PBPK models of nanomedicines.…”
Section: Discussionmentioning
confidence: 99%
“…ML and AI models are useful to predict PBPK-related parameters, such as in vitro dissolution rate, hepatic clearance, and membrane permeability of small molecular drugs; 54 , 55 and these parameters are in turn helpful to support PBPK model development. While ML and AI methods have been applied to support PBPK model development of small molecular drugs, 54 , 55 they have not been applied to develop PBPK models of nanomedicines. ML and AI models are known to be relatively complex and require a large amount of data to train and evaluate.…”
Section: Discussionmentioning
confidence: 99%
“…In pharmaceutical science, the MD simulation has gradually become an increasingly vital tool to help scientists understand the drug delivery mechanism of dissolution, solubility, controlled release, and targeted delivery 21 . In the past ten years, our group had investigated numerous dosage forms, including the preparation and dissolution behavior of solid dispersion 22 , 23 , the interaction between drug and cyclodextrin 24 , liposome 25 , drug–phospholipid complex 19 , self-assembly platinum prodrug 26 .…”
Section: Introductionmentioning
confidence: 99%
“…Over the last decade, interest regarding the use of ML algorithms across diverse disciplines in pharmaceutical design and development has grown [ 11 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 ]. While ML models have been produced to optimise lipid-based formulation (LBF) development [ 3 , 22 , 27 , 28 , 29 , 30 , 31 , 32 , 33 ], the application of more novel ML approaches for bio-enabling formulations currently focuses on solid dispersions (SDs) [ 21 , 34 , 35 ]. However, their application to LBFs, particularly supersaturated LBFs (sLBFs), remains unexplored.…”
Section: Introductionmentioning
confidence: 99%